How to Buy Uipath Stock
Uipath Inc
Uipath is a software infrastructure company located in New York, United States, which is part of the Technology sector, and is traded under the ticker PATH on the NYSE exchange.
Uipath stock last closed at $11.71, up 1.39% from the previous day, and has decreased 8.87% in one year. It has overperformed other stocks in the Software - Infrastructure industry by 0.71 percentage points. Uipath stock is currently +27.28% from its 52-week low of $9.20, and -40.98% from its 52-week high of $19.84.
As of Jul 2, 2026, there are 518.12M shares of PATH outstanding. The market cap of PATH is $6.07B. In the last 24 hours, 58.4M PATH shares were traded.
How to Buy Uipath Stock
Not sure how to invest in Uipath stock? Here's how.
- Figure out where to buy Uipath stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Uipath stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Uipath stock: The Uipath ticker symbol is PATH. Is Uipath stock a good investment? Should you buy shares of PATH? How do PATH's underlying business fundamentals look? Do top analysts think Uipath is a good buy? Why has PATH's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PATH is a good stock to buy).
- Place your PATH trade: Decide if you will purchase PATH shares at the current market price or use a limit order to buy PATH stock at a specific price.
- Monitor your PATH position: Create a watchlist to track your position in Uipath shares.
Step 1: Figure out where to buy Uipath stock
You need a brokerage account to access the NYSE market and buy PATH shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you are able to invest in PATH today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on the best app for stock investing, your next step is to transfer the money for your investment:
Check out the video below to see the process of transferring money into your new investment account.
Step 4: Evaluate Uipath stock
Once you have identified the best place to buy Uipath stock, it's absolutely critical to evaluate their stock before you buy, so you can wrap your head around the risk and upside.
Uipath shares at a glance
Uipath Due Diligence Score
WallStreetZen was designed to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on PATH's stock page.
Is PATH stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PATH's true value.
Using relative valuations methods:
- PATH could be undervalued based on its P/E ratio of 19.52x, relative to Software - Infrastructure industry P/E ratio of -278.41x
- PATH may be undervalued based on its P/B ratio of 3.19x, relative to Software - Infrastructure industry P/B ratio of 7.69x
- PATH may be overvalued based on its PEG ratio of 1.29x
You can do additional valuation analysis on PATH's stock here.
PATH Financial Health
Pros:
- PATH's operating cash flow of $384.13M allows it to safely service it's debt of $71.99M.
- There are more short-term assets than short-term liabilities on the PATH balance sheet.
- PATH profit margin has gone up from -4.7% to 19.6% in the past year.
- PATH earnings of $161.32M is not sufficient to cover its interest payments.
- There are more short-term assets than long-term liabilities on the PATH balance sheet.
Cons:
- Total PATH debt is higher than 5 years ago, relative to shareholder equity.
- PATH has a relatively high debt to equity ratio of 0.53.
Is it a good time to buy PATH stock, according to Wall Street analysts?
Out of 13 sell side analysts who monitor PATH, the consensus analyst rating on PATH is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent PATH Analyst Upgrades/Downgrades
Scott Berg, a bottom 1% analyst from Needham reiterates PATH with a buy rating and maintains their PATH price target from $15.00 to $15.00, on May 29, 2026.
Kingsley Crane, a top 15% analyst from Canaccord Genuity maintains PATH with a strong buy rating and lowers their PATH price target from $19.00 to $15.00, on Mar 12, 2026.
Terry Tillman, a bottom 7% analyst from Truist Securities maintains PATH with a hold rating and lowers their PATH price target from $17.00 to $12.00, on Mar 12, 2026.
Truist Securities's Terry Tillman lowered their price target on Uipath (NYSE: PATH) by 29.4% from $17 to $12 on 2026/03/12. The analyst maintained their Hold rating on the stock.
UiPath reported its Q4 and FY 2026 earnings.
According to Tillman, the company's continued sales execution and progress in AI-driven automation were the highlights of its solid quarter.
Management disclosed that Maestro is becoming more popular as an orchestration layer for agent workflow and for more advanced vertical automation capabilities, thanks to the purchase of WorkFusion, the analyst told readers.
Tillman noted that Software sector valuation compression drove their price target decrease.
Earnings Report
UiPath reported:
For Q4 2026:
- EPS of $0.30, which beat the Zacks Consensus Estimate of $0.25 and, by 15.4%, Q4 2025’s $0.26.
- Revenue of $481.11M, which beat the Zacks Consensus Estimate by 3.50% and, by 14%, Q4 2025’s $423.65M.
For FY 2026:
- EPS of $0.72, up 35.6% Y/Y.
- Revenue of $1.61B, up 13% Y/Y.
Management guided:
For Q1 2027:
- Revenue of $395M to $400M.
For FY 2027:
- Revenue of $1.754B to $1.759B.
Founder & CEO Daniel Dines commented: “We delivered a strong quarter and closed out a year of disciplined execution, with ARR growing 11% Y/Y to $1.853B.
“As enterprise AI adoption moves from experimentation to scaled deployment, customers increasingly need a platform that can execute complex processes with reliability, governance, and scale.
“By bringing deterministic automation, agentic AI, and enterprise-grade orchestration together on a single platform, UiPath provides the execution layer enterprises trust to run mission-critical processes in the agentic era.”
Bryan C. Bergin, a bottom 45% analyst from TD Cowen maintains PATH with a hold rating and lowers their PATH price target from $16.00 to $13.00, on Mar 12, 2026.
Michael Turrin, a bottom 1% analyst from Wells Fargo maintains PATH with a hold rating and lowers their PATH price target from $14.00 to $13.00, on Mar 12, 2026.
You can dive deeper into what analysts are projecting on the Uipath stock forecast page.
PATH Trading Indicators
PATH Performance Metrics
Last year, PATH revenue was $1.67B. Over the last 5 year, PATH's revenue has gone up by 19.69% per year. This was faster than the Software - Infrastructure industry average of 19.29%.
Learn more about PATH's earnings and revenue performance here.
Who is buying/selling PATH?
Over the past year, executives and large shareholders at PATH have sold more shares than they have bought.
Brad Brubaker, GC Chief Legal Officer of PATH, was the latest PATH insider to sell. They sold $67,513.57 worth of PATH shares on Jul 1, 2026.
Research more about who owns PATH stock here.
Can I get consistent income from PATH stock?
No, Uipath doesn't provide an income stream by paying out dividends.
What do other traders have to say about PATH?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your PATH trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Monitor your PATH position
Now that you own some PATH shares, you'll want to keep up with your stock purchase.
Start a watchlist to track the latest developments regarding your PATH stock.
PATH Feed
How to Buy Stock in Uipath
To summarize, here are the 6 steps you need to take to buy Uipath stock right now:
- Figure out where to buy Uipath stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Evaluate Uipath stock
- Place your PATH trade
- Monitor your PATH position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Uipath, click below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.